Optical Spectroscopy Classification with Error Rejection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for classifying optical spectroscopy data for cancer and other pathologies have limitations in sensitivity and specificity, often resulting in invasive procedures and high false-negative rates, necessitating improved diagnostic accuracy.
Innovation Solution
A method involving training classifiers to determine a rejection region for biomedical spectra data, combining classifications from multiple classifiers using support vector machines with embedded error rejection, and incorporating feature selection techniques like Sequential Floating Forward Selection and Principal Component Analysis to enhance diagnostic decision-making.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If optical spectroscopy methods are used for tissue classification, then noninvasive real-time diagnosis is achieved, but sensitivity and specificity are insufficient leading to high false-negative rates
Solution Approach 1:
The patent combines multiple spectroscopy techniques (Raman, autofluorescence, fluorescence, reflectance, and elastic-scattering spectroscopy) into an integrated diagnostic system. By merging these different optical methods, the system achieves both noninvasive real-time operation and improved diagnostic reliability through complementary information from multiple spectral modalities
Solution Approach 2:
The patent employs composite classification algorithms that integrate multiple machine learning approaches (support vector machines, neural networks, decision trees) to process spectroscopy data. This composite analytical framework enhances sensitivity and specificity while maintaining the noninvasive real-time diagnostic capability
2Reliability
If invasive biopsy procedures are performed to improve diagnostic accuracy, then sensitivity and specificity increase, but patient distress and healthcare costs increase
Solution Approach 1:
The patent replaces the mechanical invasive biopsy procedure with an optical spectroscopy-based diagnostic system. The optical probe uses noninvasive light interaction with tissue to obtain spectral information, eliminating the need for surgical tissue removal while achieving comparable or superior diagnostic accuracy through advanced pattern recognition
Solution Approach 2:
The patent introduces optical spectroscopy as an intermediary diagnostic method between visual inspection and invasive biopsy. The spectroscopic analysis serves as a noninvasive mediator that provides sufficient diagnostic information to avoid unnecessary biopsies while maintaining high diagnostic reliability
3Measurement precision
If multiple random biopsies are taken to detect pre-cancerous changes, then detection sensitivity improves, but procedure time and complexity increase
Solution Approach 1:
The patent extracts the diagnostic function from multiple random biopsy procedures and concentrates it in a single optical spectroscopy measurement. The optical probe captures spectral information from the entire tissue volume in one noninvasive measurement, eliminating the need for multiple sequential biopsies and their associated complexity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach improves the accuracy of tissue classification by identifying samples at high risk of misclassification, reducing the need for invasive procedures and enhancing diagnostic reliability through improved sensitivity and specificity.
Implementation Method 1
Some of these proposed spectroscopic techniques include Raman spectroscopy
Implementation Method 2
autofluorescence spectroscopy
Implementation Method 3
fluorescence spectroscopy
Implementation Method 4
reflectance spectroscopy
Implementation Method 5
elastic-scattering spectroscopy
Data Source
Figure 1A~2B
Figure 3
Figure 4
AI summary
Mathematical/statistical pattern-recognition systems and methods to distinguish between different pathologies and benign conditions (e.g., normal or cancerous tissue) given spectra measured using optical spectroscopy such as elastic-scattering spectroscopy.